Table 1 Characteristics of patients receiving IV pantoprazole before and after of guideline establishment
Characteristic | Pre intervention Number (%) | Post intervention Number (%) | P valueb |
|---|---|---|---|
Male | 85 (42.5) | 118 (59.0) | 0.01 |
Female | 115 (57.5) | 82 (41.0) | |
Age (years) | |||
Mean ± SDb | 54.56 ± 1.273 | 48.09 ± 1.493 | |
<20 | 5 (2.5) | 27 (13.5) | 0.01 |
20–30 | 15 (7.5) | 21 (10.5) | |
30–40 | 26 (13) | 22 (11) | |
40–50 | 29 (14.5) | 37 (18.5) | |
50–60 | 53 (26.5) | 39 (19.5) | |
60–70 | 30 (15) | 21 (10.5) | |
>70 | 21 (10.5) | 33 (16.5) | |
NPO | 54 (27.0) | 99 (49.5) | 0.00 |
PO | 146 (73.0) | 101 (50.5) | |
History of PPI administration | 59 (29.5) | 37 (18.5) | 0.33 |
History of GI disease | 75 (37.0) | 52 (26.5) | 0.05 |
Death | 1 (0.5) | 1 (0.5) | 1.00 |